📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

A Phase II, Open-label study to assess safety and management change using 68Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study. (2021)

First Author: Afaq A
Attributed to:  Next generation molecular imaging and therapy with radionuclides funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2967/jnumed.120.257527

PubMed Identifier: 33741648

Publication URI: http://europepmc.org/abstract/MED/33741648

Type: Journal Article/Review

Volume: 62

Parent Publication: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Issue: 12

ISSN: 0161-5505